Firm News

The FDA Has Issued Increased Warnings for Depakote Use During Pregnancy

By Burg Simpson

May 6, 2013  

“The FDA released a MedWatch safety alert today to increase the warnings for valproate products, such as Depakote® (divalproex sodium), Depacon® (valproate sodium), Depakene® (valproic acid), Stavzor® (valproic acid), and their generics. Valproate products are approved for the treatment of epilepsy, manic episodes associated with bipolar disorder, and prevention of migraine headaches. However, today the FDA warned…”

Top 100 National Trial Lawyers Legal 500 Best Lawyers in America Super Lawyers US News 2014 Top 25 Most Influential Lawyers